Pathstone Holdings’s Accendra Health ACH Stock Holding History

Pathstone Holdings’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,130	Closed	-$101K	–	2292
2025 Q1	$101K	Buy	+11,130	New	+$118K	﹤0.01%	2144

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pathstone Holdings's ACH Position: Q2 2025 in Review

Pathstone Holdings sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 11,130 shares — an estimated $101K sold.

Pathstone Holdings first reported a position in ACH in Q1 2025 and held it in 1 quarter. The position peaked at $101K in Q1 2025. 235 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

Pathstone Holdings reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
Pathstone Holdings sold 11,130 Accendra Health shares in Q2 2025, an estimated $101K.
Pathstone Holdings first reported a position in Accendra Health in Q1 2025 and held it in 1 quarter.
Pathstone Holdings's Accendra Health position peaked at $101K in Q1 2025.
235 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.